Medical Weight Loss for Kansas City, Kansas Residents
Kansas City, Kansas residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Kansas City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Kansas City Residents Choose New Hope Weight Loss
Kansas City patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Kansas and beyond since 2020.
From our Costa Mesa, California practice, we provide Kansas City with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
In Kansas City, Kansas, you do not need a local clinic to begin: our physician-led program reaches you by telehealth. We care for patients throughout the greater Wyandotte County area and the Kansas side of metro Kansas City, with bilingual Spanish care. Spanish-speaking Kansas City patients complete the entire program, intake, consultation, and follow-up, in Spanish with our bilingual team.
Whether you live in central Kansas City or its outskirts, you get exactly the same care and the same price. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you before you begin.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Kansas City
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Kansas City
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Kansas City address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Kansas City
How do I get treatment from Kansas City?
As a Kansas City, Kansas patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Kansas City?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Kansas City in cold-pack packaging, no lines and no drive.
How much does it cost for Kansas City patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Kansas City do you serve?
We serve patients from across Kansas City by telehealth, including the greater Wyandotte County area and the Kansas side of metro Kansas City, with bilingual Spanish care.
How does telehealth treatment work for Kansas City patients?
You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Kansas City address. Follow-ups also happen by video.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kansas City, Kansas by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.